GlassScriptPhysician profile
Nicholas Major
NPI 1407439771
$6,666.98
in general payments reported to CMS, 2019-2025
12 companies · $2,074 in 2025
The $2,074 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $60.24 · 2022: $299 · 2023: $3,391 · 2024: $842 · 2025: $2,074.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,301 · Travel and Lodging: $3,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,300.74 |
| Travel and Lodging | $3,007.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,785.58 | 2021-2025 | Ams 700, Lithovue, Advance Xp |
| Medtronic, INC. | $1,475.61 | 2024-2025 | Interstim |
| Janssen Scientific Affairs, LLC | $245.28 | 2024-2025 | Erleada, Akeega, Balversa |
| Photocure INC | $239.47 | 2024-2025 | Cysview |
| Urogen Pharma, INC. | $237.10 | 2022-2023 | Jelmyto |
| Calyxo, INC. | $144.98 | 2025 | Cvac Aspiration System |
| Olympus America INC. | $140.47 | 2024 | Itind System |
| Edap Technomed INC | $115.36 | 2025 | |
| Sumitomo Pharma America, INC. | $109.44 | 2023 | Gemtesa |
| Karl Storz Endoscopy-America | $81.22 | 2023 | Tele Pack |
| Progenics Pharmaceuticals, INC. | $52.85 | 2024 | |
| Myriad Genetic Laboratories, INC. | $39.62 | 2023 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Major listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.